Ms. Martie Griffin has served as Vice President of Corporate Quality and Pharmacovigilance at Eloxx since January 2019 and has concurrently served as Vice President of Regulatory Affairs since March 2020. Ms. Griffin is an accomplished Compliance and Quality Assurance leader with extensive experience establishing and maintaining regulatory compliance strategies and GxP Quality Management Systems to ensure global corporate adherence to all applicable regulatory healthcare laws and regulations. Previously, Ms. Griffin served as Vice President, Quality Assurance and Compliance at Radius Health, and held the same title previously at Micromet (acquired by Amgen), and Celtic Pharma. Ms. Griffin was the Senior Director GCP Compliance at the Medicines Company and served as the Director, Corporate Pharmaceutical Regulatory Monitoring at Pfizer, Inc. Earlier in her career, Ms. Griffin held positions with increasing responsibilities at Covance Inc., BioResearch Monitors, Inc., Applied Immune Sciences, and Synergen, Inc. Ms. Griffin received her B.S. in Nursing from the Catholic University of America and her Critical Care Registered Nurse certification from the University of London, Royal College of Nursing, International Health Sciences. Ms. Griffin holds two M.B.A. degrees; one in International Business Administration, and the second in Marketing from the American Intercontinental University.